EP3416684
AÐFERÐIR VIÐ MEÐFERÐ EÐA VIÐ AÐ HINDRA FITUHRÖRNUN MEÐ ÞVÍ AÐ GEFA ANGPTL3-HEMIL
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.2.2017EP published:
21.6.2023EP application number:
17706945.7
EP translation filed:
19.7.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
12.2.2037Expiry date:
12.2.2027Next due date:
28.2.2027
Title in English:
METHODS FOR TREATING OR PREVENTING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF ANGPTL3Language of the patent:
English
Timeline
Today
13.2.2017EP application
21.6.2023EP Publication
19.7.2023Translation submitted
15.9.2023Registration published
12.2.2027Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
GROMADA, JesperAddress:
Tarrytown, New York 10591, US
Name:
GUSAROVA, ViktoriaAddress:
Tarrytown, New York 10591, US
Name:
MURPHY, Andrew J.Address:
Tarrytown, New York 10591, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201662296110 PDate:
17.2.2016Country:
US
Classification
Categories:
A61K 39/395, C07K 16/22, A61P 3/06
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 23.1.2024
Expires: 12.2.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 23.1.2024
Expires: 12.2.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 29.1.2025
Expires: 12.2.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 13.2.2026
Expires: 12.2.2027
Payer: Árnason Faktor ehf.